Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Long-Term Deferred Tax (2021 - 2026)

Ironwood Pharmaceuticals' Long-Term Deferred Tax history spans 5 years, with the latest figure at $103.4 million for Q4 2025.

  • On a quarterly basis, Long-Term Deferred Tax fell 28.29% to $103.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $103.4 million, a 28.29% decrease, with the full-year FY2025 number at $103.4 million, down 28.29% from a year prior.
  • Long-Term Deferred Tax hit $103.4 million in Q4 2025 for Ironwood Pharmaceuticals, up from $101.7 million in the prior quarter.
  • Over the last five years, Long-Term Deferred Tax for IRWD hit a ceiling of $337.8 million in Q2 2021 and a floor of $101.7 million in Q3 2025.
  • Historically, Long-Term Deferred Tax has averaged $233.6 million across 5 years, with a median of $243.6 million in 2023.
  • Biggest five-year swings in Long-Term Deferred Tax: decreased 5.11% in 2022 and later crashed 45.13% in 2025.
  • Tracing IRWD's Long-Term Deferred Tax over 5 years: stood at $333.3 million in 2021, then fell by 14.89% to $283.7 million in 2022, then decreased by 25.15% to $212.3 million in 2023, then crashed by 32.07% to $144.2 million in 2024, then decreased by 28.29% to $103.4 million in 2025.
  • Business Quant data shows Long-Term Deferred Tax for IRWD at $103.4 million in Q4 2025, $101.7 million in Q3 2025, and $129.5 million in Q2 2025.